{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T22:05:43Z","timestamp":1751753143407,"version":"3.40.5"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T00:00:00Z","timestamp":1674432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T00:00:00Z","timestamp":1674432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Science and Technology Development Fund of Shanghai Pudong New Area","award":["PKJ2021-Y07","PKJ2021-Y07","PKJ2021-Y07","PKJ2021-Y07","PKJ2021-Y07","PKJ2021-Y07","PKJ2021-Y07","PKJ2021-Y07","PKJ2021-Y07","PKJ2021-Y07","PKJ2021-Y07"],"award-info":[{"award-number":["PKJ2021-Y07","PKJ2021-Y07","PKJ2021-Y07","PKJ2021-Y07","PKJ2021-Y07","PKJ2021-Y07","PKJ2021-Y07","PKJ2021-Y07","PKJ2021-Y07","PKJ2021-Y07","PKJ2021-Y07"]}]},{"name":"Medical Discipline Construction Project of the Pudong Health Committee of Shanghai","award":["PWYgf2021-02","PWYgf2021-02","PWYgf2021-02","PWYgf2021-02","PWYgf2021-02","PWYgf2021-02","PWYgf2021-02","PWYgf2021-02","PWYgf2021-02","PWYgf2021-02","PWYgf2021-02"],"award-info":[{"award-number":["PWYgf2021-02","PWYgf2021-02","PWYgf2021-02","PWYgf2021-02","PWYgf2021-02","PWYgf2021-02","PWYgf2021-02","PWYgf2021-02","PWYgf2021-02","PWYgf2021-02","PWYgf2021-02"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Thrombosis J"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Portal vein thrombosis is a common complication of liver cirrhosis and hepatocellular carcinoma; however, few studies have reported its long-term clinical prognosis. This study aimed to establish and validate easy-to-use nomograms for predicting gastrointestinal bleeding, portal vein thrombosis resolution, and mortality of patients with portal vein thrombosis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This multicenter retrospective cohort study included 425 patients with portal vein thrombosis who were divided into training (<jats:italic>n<\/jats:italic>\u2009=\u2009334) and validation (<jats:italic>n<\/jats:italic>\u2009=\u200991) sets. Prediction models were developed using multivariate Cox regression analysis and evaluated using the consistency index and calibration plots.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Predictors of gastrointestinal bleeding included a history of gastrointestinal bleeding, superior mesenteric vein thrombosis, red color sign observed during endoscopy, and hepatic encephalopathy. Meanwhile, predictors of resolution of portal vein thrombosis included a history of abdominal infection, C-reactive protein and hemoglobin levels, and intake of thrombolytics. Predictors of death included abdominal infection, abdominal surgery, aspartate aminotransferase level, hepatic encephalopathy, and ascites. All models had good discriminatory power and consistency. Anticoagulation therapy significantly increased the probability of thrombotic resolution without increasing the risk of bleeding or death.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We successfully developed and validated three prediction models that can aid in the early evaluation and treatment of portal vein thrombosis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12959-023-00455-w","type":"journal-article","created":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T10:03:08Z","timestamp":1674468188000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Development and external validation of prognostic scoring models for portal vein thrombosis: a multicenter retrospective study"],"prefix":"10.1186","volume":"21","author":[{"given":"Xuan","family":"Zhong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiali","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinlai","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinjuan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changqing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6947-3266","authenticated-orcid":false,"given":"Lan","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,1,23]]},"reference":[{"key":"455_CR1","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1002\/hep.22772","volume":"49","author":"LD DeLeve","year":"2009","unstructured":"DeLeve LD, Valla DC, Garcia-Tsao G. American Association for the Study Liver Diseases Vascular disorders of the liver. Hepatology. 2009;49:1729\u201364.","journal-title":"Hepatology"},{"key":"455_CR2","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jhep.2015.07.040","volume":"64","author":"European Association for the Study of the Liver","year":"2016","unstructured":"European Association for the Study of the Liver. EASL clinical practice guidelines: vascular diseases of the liver. J Hepatol. 2016;64:179\u2013202.","journal-title":"J Hepatol"},{"issue":"36","key":"455_CR3","first-page":"2667","volume":"2020","author":"Hepatobiliary Disease Study Group","year":"2020","unstructured":"Hepatobiliary Disease Study Group, Chinese Society of Gastroenterology, Chinese Medical Association. Consensus for management of portal vein thrombosis in liver cirrhosis (2020, Shanghai). J Dig Dis. 2020;2020(36):2667\u201374.","journal-title":"J Dig Dis"},{"key":"455_CR4","first-page":"315","volume":"31","author":"A Mantaka","year":"2018","unstructured":"Mantaka A, Augoustaki A, Kouroumalis EA, Samonakis DN. Portal vein thrombosis in cirrhosis: diagnosis, natural history, and therapeutic challenges. Ann Gastroenterol. 2018;31:315\u201329.","journal-title":"Ann Gastroenterol"},{"key":"455_CR5","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1111\/jth.12930","volume":"13","author":"N Riva","year":"2015","unstructured":"Riva N, Poli D, Testa S, Rupoli S, et al. Safety of vitamin K antagonist treatment for splanchnic vein thrombosis: a multicenter cohort study. J Thromb Haemost. 2015;13:1019\u201327.","journal-title":"J Thromb Haemost"},{"key":"455_CR6","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.3748\/wjg.v12.i13.2115","volume":"12","author":"M Ogren","year":"2006","unstructured":"Ogren M, Bergqvist D, Bjorck M, et al. Portal vein thrombosis: prevalence, patient characteristics and lifetime risk: a population study based on 23,796 consecutive autopsies. World J Gastroenterol: WJG. 2006;12:2115\u20139.","journal-title":"World J Gastroenterol: WJG"},{"key":"455_CR7","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1111\/j.1478-3231.2012.02785.x","volume":"32","author":"M Senzolo","year":"2012","unstructured":"Senzolo M, Sartori TM, Valeria R, et al. Prospective evaluation of anticoagulation and transjugular intrahepatic portosistemic shunt for the management of portal vein thrombosis in cirrhosis. Liver Int. 2012;32:919\u201327.","journal-title":"Liver Int"},{"key":"455_CR8","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1002\/hep.23259","volume":"51","author":"A Plessier","year":"2010","unstructured":"Plessier A, Darwish-Murad S, Hernandez-Guerra M, et al. Acute portal vein thrombosis unrelated to cirrhosis: a prospective multicenter follow-up study. Hepatology. 2010;51:210\u20138.","journal-title":"Hepatology"},{"key":"455_CR9","doi-asserted-by":"publisher","first-page":"384","DOI":"10.3350\/cmh.2014.20.4.384","volume":"20","author":"JW Chung","year":"2014","unstructured":"Chung JW, Kim GH, Lee JH, Ok KS, Jang ES, et al. Safety, efficacy, and response predictors of anticoagulation for the treatment of nonmalignant portal-vein thrombosis in patients with cirrhosis: a propensity score matching analysis. Clin Mol Hepatol. 2014;20:384\u201391.","journal-title":"Clin Mol Hepatol"},{"key":"455_CR10","doi-asserted-by":"publisher","first-page":"10062","DOI":"10.3748\/wjg.v21.i35.10062","volume":"21","author":"A Blasi","year":"2015","unstructured":"Blasi A. Coagulopathy in liver disease: lack of an assessment tool. World J Gastroenterol. 2015;21:10062\u201371.","journal-title":"World J Gastroenterol"},{"key":"455_CR11","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1002\/hep.28466","volume":"63","author":"C Noronha Ferreira","year":"2016","unstructured":"Noronha Ferreira C, Seijo S, Plessier A, et al. Natural history and management of esophagogastric varices in chronic noncirrhotic, nontumoral portal vein thrombosis. Hepatology. 2016;63:1640\u201350.","journal-title":"Hepatology"},{"key":"455_CR12","first-page":"1265","volume":"40","author":"W Xu","year":"2020","unstructured":"Xu W, Cheng Y, Tu B. Construction and validation of a nomogram for predicting the risk of portal vein thrombosis after splenectomy in patients with hepatitis B cirrhosis. Nan Fang Yi Ke Da Xue Xue Bao. 2020;40:1265\u201372.","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"455_CR13","doi-asserted-by":"publisher","first-page":"218","DOI":"10.11152\/mu.2013.2066.182.pvt","volume":"18","author":"M Danila","year":"2016","unstructured":"Danila M, Sporea I, Popescu A, et al. Portal vein thrombosis in liver cirrhosis - the added value of contrast enhanced ultrasonography. Med Ultrason. 2016;18:218\u201333.","journal-title":"Med Ultrason"},{"key":"455_CR14","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/ajg.2012.452","volume":"108","author":"H Maruyama","year":"2013","unstructured":"Maruyama H, Okugawa H, Takahashi M, Yokosuka O, et al. De novo portal vein thrombosis in virus-related cirrhosis: predictive factors and long-term outcomes. Am J Gastroenterol. 2013;108:568\u201374.","journal-title":"Am J Gastroenterol"},{"key":"455_CR15","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/s41395-018-0421-0","volume":"114","author":"I Pettinari","year":"2019","unstructured":"Pettinari I, Vukotic R, Stefanescu H, et al. Clinical impact and safety of anticoagulants for portal vein thrombosis in cirrhosis. Am J Gastroenterol. 2019;114:258\u201366.","journal-title":"Am J Gastroenterol"},{"key":"455_CR16","doi-asserted-by":"crossref","unstructured":"Turnes J, Garc\u00eda-Pag\u00e1n JC, Gonz\u00e1lez M, Aracil C, et al. Portal hypertension-related complications after acute portal vein thrombosis: impact of early anticoagulation. Clin Gastroenterol Hepatol. 2008;6:1412\u20137.","DOI":"10.1016\/j.cgh.2008.07.031"},{"key":"455_CR17","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1002\/lt.24387","volume":"22","author":"H Chen","year":"2016","unstructured":"Chen H, Turon F, Hern\u00e1ndez-Gea V, Fuster J, Garcia-Criado A, et al. Nontumoral portal vein thrombosis in patients awaiting liver transplantation. Liver Transplant. 2016;22:352\u201365.","journal-title":"Liver Transplant"},{"key":"455_CR18","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ejim.2014.12.002","volume":"26","author":"X Qi","year":"2015","unstructured":"Qi X, De Stefano V, Li H, Dai J, Guo X, et al. Anticoagulation for the treatment of portal vein thrombosis in liver cirrhosis: a systematic review and meta-analysis of observational studies. Eur J Intern Med. 2015;26:23\u20139.","journal-title":"Eur J Intern Med"},{"key":"455_CR19","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.vph.2018.05.002","volume":"113","author":"AS Hanafy","year":"2019","unstructured":"Hanafy AS, Abd-Elsalam S, Dawoud MM. Randomized controlled trial of rivaroxaban versus warfarin in the management of acute non-neoplastic portal vein thrombosis. Vascul Pharmacol. 2019;113:86\u201391.","journal-title":"Vascul Pharmacol"},{"key":"455_CR20","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1111\/j.1572-0241.2003.07338.x","volume":"98","author":"S Kumar","year":"2003","unstructured":"Kumar S, Kamath PS. Acute superior mesenteric venous thrombosis: one disease or two? Am J Gastroenterol. 2003;98:1299\u2013304.","journal-title":"Am J Gastroenterol"},{"key":"455_CR21","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1001\/jamainternmed.2015.3184","volume":"175","author":"W Ageno","year":"2015","unstructured":"Ageno W, Riva N, Schulman S, et al. Long-term clinical outcomes of splanchnic vein thrombosis. JAMA Intern Med. 2015;175:1474\u201380.","journal-title":"JAMA Intern Med"},{"key":"455_CR22","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.bcmd.2017.10.006","volume":"70","author":"DA Gell","year":"2018","unstructured":"Gell DA. Structure and function of haemoglobins. Blood Cells Mol Dis. 2018;70:13\u201342.","journal-title":"Blood Cells Mol Dis"},{"key":"455_CR23","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.thromres.2003.09.018","volume":"111","author":"HA Liebman","year":"2003","unstructured":"Liebman HA, Feinstein DI. Thrombosis in patients with paroxysmal noctural hemoglobinuria is associated with markedly elevated plasma levels of leukocyte-derived tissue factor. Thromb Res. 2003;111:235\u20138.","journal-title":"Thromb Res"},{"key":"455_CR24","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jhep.2014.03.014","volume":"61","author":"G Mehta","year":"2014","unstructured":"Mehta G, Augoustaki A, Kouroumalis EA, Samonakis DN. Inflammation and portal hypertension - the undiscovered country. J Hepatol. 2014;61:155\u201363.","journal-title":"J Hepatol"},{"key":"455_CR25","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1182\/blood.2019003603","volume":"135","author":"AJ Darzi","year":"2020","unstructured":"Darzi AJ, Karam SG, Charide R, Etxeandia-Ikobaltzeta I, et al. Prognostic factors for VTE and bleeding in hospitalized medical patients: a systematic review and meta-analysis. Blood. 2020;135:1788\u2013810.","journal-title":"Blood"},{"key":"455_CR26","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1053\/j.gastro.2019.01.265","volume":"156","author":"NM Intagliata","year":"2019","unstructured":"Intagliata NM, Caldwell SH, Tripodi A. Diagnosis, development, and treatment of portal vein thrombosis in patients with and without cirrhosis. Gastroenterology. 2019;156:1582\u201399.","journal-title":"Gastroenterology"},{"key":"455_CR27","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1055\/s-2002-33210","volume":"34","author":"L Amitrano","year":"2002","unstructured":"Amitrano L, Brancaccio V, Guardascione MA, Margaglione M, et al. Portal vein thrombosis after variceal endoscopic sclerotherapy in cirrhotic patients: role of genetic thrombophilia. Endoscopy. 2002;34:535\u20138.","journal-title":"Endoscopy"},{"key":"455_CR28","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.21037\/atm-20-2444","volume":"8","author":"SF Wang","year":"2020","unstructured":"Wang SF, Huang YT, Huang CH, et al. Fibrosis index predicts variceal bleeding and reduces need for nonselective beta-blocker in compensated cirrhosis with initial small esophageal varices without red-color sign. Ann Transl Med. 2020;8:1223.","journal-title":"Ann Transl Med"},{"key":"455_CR29","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1136\/gut.36.1.100","volume":"36","author":"PA McCormick","year":"1995","unstructured":"McCormick PA, Jenkins SA, McIntyre N, et al. Why portal hypertensive varices bleed and bleed: a hypothesis. Gut. 1995;36:100\u20133.","journal-title":"Gut"},{"key":"455_CR30","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.gtc.2014.08.011","volume":"43","author":"SK Satapathy","year":"2014","unstructured":"Satapathy SK, Sanyal AJ. Nonendoscopic management strategies for acute esophagogastric variceal bleeding. Gastroenterol Clin North Am. 2014;43:819\u201333.","journal-title":"Gastroenterol Clin North Am"},{"key":"455_CR31","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/S1665-2681(19)31301-8","volume":"12","author":"BV John","year":"2013","unstructured":"John BV, Konjeti R, Aggarwal A, Lopez R, Atreja A, Miller C, et al. Impact of untreated portal vein thrombosis on pre and post liver transplant outcomes in cirrhosis. Ann Hepatol. 2013;12:952\u20138.","journal-title":"Ann Hepatol"},{"key":"455_CR32","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1111\/jth.12121","volume":"11","author":"MC Spaander","year":"2013","unstructured":"Spaander MC, Hoekstra J, Hansen BE, Van Buuren HR, Leebeek FW, Janssen HL. Anticoagulant therapy in patients with non-cirrhotic portal vein thrombosis: effect on new thrombotic events and gastrointestinal bleeding. J Thromb Haemost. 2013;11:452\u20139.","journal-title":"J Thromb Haemost"}],"container-title":["Thrombosis Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12959-023-00455-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12959-023-00455-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12959-023-00455-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T10:06:21Z","timestamp":1674468381000},"score":1,"resource":{"primary":{"URL":"https:\/\/thrombosisjournal.biomedcentral.com\/articles\/10.1186\/s12959-023-00455-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,23]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["455"],"URL":"https:\/\/doi.org\/10.1186\/s12959-023-00455-w","relation":{},"ISSN":["1477-9560"],"issn-type":[{"type":"electronic","value":"1477-9560"}],"subject":[],"published":{"date-parts":[[2023,1,23]]},"assertion":[{"value":"16 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures were performed following the ethical standards of the responsible committee on human experimentation (institutional and national) and in accordance with the Helsinki Declaration of 1975, as revised in 2008. This study was approved by the Human Participants Ethics Committees of the two hospitals ([2022] Research Approval No. 012). Informed Consent: We obtained written informed consent from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9"}}